Pathology Systems Reagents Consumables and Managed Service

Pathology Systems Reagents Consumables and Managed Service for NHS Supply Chain

Provision of a single and multi-discipline managed service for laboratory equipment maintenance and supply of all associated consumables and reagents. Precise quantities are unknown. Pre-tender meetings probably required – details below.

UK-Normanton: Laboratory services

2013/S 037-058473

Prior information notice

Supplies

Directive 2004/18/EC

Section I: Contracting authority

I.1)Name, addresses and contact point(s)

NHS Supply Chain acting as agent for NHS Business Services Authority
NHS Supply Chain, Foxbridge Way
For the attention of: Michael Culshaw
WF6 1TL Normanton
UNITED KINGDOM
Telephone: +44 7714041831
E-mail: michael.culshaw@supplychain.nhs.uk
Fax: +44 1244852633

Internet address(es):

General address of the contracting authority: www.supplychain.nhs.uk

Further information can be obtained from: NHS Supply Chain acting as agent for NHS Business Services Authority
Internet address: ): http://procurement.supplychain.nhs.uk/

I.2)Type of the contracting authority

National or federal agency/office
I.3)Main activity

Health
I.4)Contract award on behalf of other contracting authorities

The contracting authority is purchasing on behalf of other contracting authorities: yes

Section II.B: Object of the contract (Supplies or services)

II.1)Title attributed to the contract by the contracting authority:

Pathology Systems Reagents Consumables and Managed Service
II.2)Type of contract and place of delivery or of performance

Supplies
Various locations in UK.
NUTS code UK

II.3)Information on framework agreement
II.4)Short description of nature and quantity or value of supplies or services:

Pathology Systems Reagents Consumables and Managed Service. Provision of a single and multi-discipline managed service for laboratory equipment maintenance and supply of all associated consumables and reagents. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of GBP 20 000 000 to GBP 30 000 000 in the first year of this Framework Agreement however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.
Estimated cost excluding VAT:
Range: between 80 000 000 and 120 000 000 GBP
II.5)Common procurement vocabulary (CPV)

71900000, 33141000, 85111800, 85111810, 33100000

II.6)Scheduled date for start of award procedures
II.7)Information about Government Procurement Agreement (GPA)

The contract is covered by the Government Procurement Agreement (GPA): yes
II.8)Additional information:

The purpose of this notice is to draw attention to a procurement that NHS Supply Chain intends to commence during the subsequent 12 months. The invitation to tender will be the subject of a separate notice and it is that notice to which potential suppliers will need to respond at the appropriate time.
The Framework Agreement between NHS Supply Chain and successful suppliers will reserve the right to purchase the same or similar supplies and/or services from suppliers not appointed to the Framework Agreement at its sole discretion.
Whilst it is anticipated that initial expenditure under any forthcoming procurement will be in the region of GBP 80 000 000 to GBP 120 000 000 for this contract award this is approximate only and the values will be to such level as those purchasing under the Framework Agreement consider necessary to provide suitable requirements.
NHS Supply Chain expects to provide successful suppliers with the opportunity to offer additional savings to customers through the provision of discounted pricing value added offerings and commitment/bulk buy initiatives.
The Framework Agreement will be between NHS Supply Chain and the Supplier. Under the Framework Agreement there will be two different methods of supply – one for Non-Direct Contract Products and one for Direct Contract Products.
NHS Supply Chain will be entitled to purchase the supplies and/or services identified in the tender documents as Non-Direct Contract Products which it will then make available for purchase by:
1) any NHS Trust;
2) any other NHS entity;
3) any government department agency or other statutory body and/or
4) any private sector entity active in the UK healthcare sector.
For the supplies and/or services identified as Direct Contract Products in the tender documents:
1) NHS Supply Chain;
2) any NHS Trust;
3) any other NHS entity;
4) any government department agency or other statutory body and/or
5) any private sector entity active in the UK healthcare sector will be able to enter into a direct contract with the Supplier for any of the supplies and/or services under the Framework.
For Direct Contract Products the Supplier will be required to report to and pay a direct contract management fee to NHS Supply Chain as detailed in the tender documents.
NHS Supply Chain is currently considering the use of lots for this procurement. However it reserves the right not to as part of any future tender process. Further information in respect of the lot strategy will be set out in the notice for the forthcoming procurement.
As part of its pre-tender strategy NHS Supply Chain anticipates engaging with suppliers of these products / services. If you would like to speak with NHS Supply Chain in respect of the products / services which are the subject of this procurement then please contact Michael Culshaw via http://procurement.supplychain.nhs.uk/

NHS Supply Chain anticipates holding pre-tender meetings with suppliers during the coming months. If you would like to attend this event please contact Michael Culshaw via http://procurement.supplychain.nhs.uk/ to register your attendance.

Section III: Legal, economic, financial and technical information

III.1)Conditions relating to the contract
III.1.1)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:

N/A.
III.2)Conditions for participation
III.2.1)Information about reserved contracts

Section VI: Complementary information

VI.1)Information about European Union funds
VI.2)Additional information:
VI.3)Information on general regulatory framework

VI.4)Date of dispatch of this notice:18.2.2013